Biolinq Announces Close of $100M Series C Financing to Advance Its Biowearable Platform for Metabolic Health
SAN DIEGO–(BUSINESS WIRE)–Biolinq Incorporated, a healthcare technology company pioneering precision multi-analyte biosensors to improve metabolic health, today announced a $100 million Series C financing led by Alpha Wave Ventures, with participation from existing investors RiverVest…